Global Blood Therapeutics
GBT
#2830
Rank
C$6.69 B
Marketcap
$99.17
Share price
0.00%
Change (1 day)
142.78%
Change (1 year)

Earnings for Global Blood Therapeutics (GBT)

Earnings in 2022 (TTM): -C$0.41 Billion

According to Global Blood Therapeutics 's latest financial reports the company's current earnings are C$0.23 Billion. In 2021 the company made an earning of -C$0.44 Billion a decrease over its 2020 earnings that were of -C$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Global Blood Therapeutics from 2014 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$0.41 Billion-6.67%
2021 -C$0.44 Billion22.24%
2020 -C$0.36 Billion-7.2%
2019 -C$0.39 Billion53.14%
2018 -C$0.26 Billion48.85%
2017 -C$0.17 Billion41.9%
2016 -C$0.12 Billion77.88%
2015 -C$67.13 Million122.81%
2014 -C$30.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA